Scientific Programme

Topics
History and perspectives of molecular targeted radiotherapy - old wine in new bottles
- From antibodies to antibodies –is there a future for radioimmunotherapy?
- The revolution started 25 years ago – SSTR agonists and antagonists
- Peptide radiochemistry – from Gallium-68 to Fluorine-18?
- New radioisotopes for theranostics – Terbium, Scandium and more
- Production of therapeutic radionuclides – will there be a bottle neck for Actinium?
- PSMA – a breakthrough in the diagnosis and treatment of prostate cancer
- FAPI – will it be the new FDG and the weapon for molecular radioligand therapy of all cancer types?
- Theranostics and Precision Cancer Medicine – from the shadows to storm the market
- Dosimetry: from retrospective to prospective?
- Artificial Intelligence, deep learning and Precision Oncology – a future without a caring physician?
- ICPO Academy for Precision Oncology (IAPO) - aims and challenges 
- Total body PET/CT – will we be able to detect micrometastases in patients in less than 30 seconds?
- From patient to patient – how support groups can improve cancer treatment

Programme Guide Download
Share by: